immun

/immun

About immun

This author has not yet filled in any details.
So far immun has created 14 blog entries.

이뮨온시아, ‘PD-L1 억제 면역항암제’ 2상 승인

By | 2020/05/22|News and Publications|

Samsung Biologics and ImmuneOncia Therapeutics Inc. Development and Manufacturing Agreement Accomplishes IND Clearance of IMC-002 (anti-CD47 antibody)

By | 2020/04/27|News and Publications|

이뮨온시아,면역항암제 후보물질 임상 계획 미국 FDA 제출

By | 2020/03/13|News and Publications|

KDDF, ‘차이나 서밋’ 참여해 국내 투자 유치 도모

By | 2019/12/04|News and Publications|

이뮨온시아, 면역함암제 임상1상 결과 공개

By | 2019/12/04|News and Publications|

사노피 출신 대표가 이끌고, 유한이 선택한 ‘그 회사’

By | 2019/10/21|News and Publications|

ImmuneOncia has been selected by the Korea Drug Development Fund to develop an immune therapy targeting a cancer-aiding protein.

By | 2019/09/19|News and Publications|

Yuhan Corp and Sorrento Therapeutics announce completion of phase 1 clinical study of anti-PD-L1 antibody IMC-001

By | 2019/03/20|News and Publications|

Yuhan Corp and Sorrento Therapeutics announce closing of a $40M USD Financing for joint venture ImmuneOncia to support advancement of Immuno-Oncology program

By | 2019/02/18|News and Publications|

Sorrento’s and Yuhan’s joint venture, ImmuneOncia, receives approval to begin clinical trial of anti-PD-L1 monoclonal antibody in South Korea

By | 2018/03/07|News and Publications|